Last 12 months
Inside the activity.
6 purchase rows · 20 sale rows
Disclosed non-derivative P/S rows, by transaction month. Includes amendments and private transactions.Monthly counts
| Month | Purchases | Sales |
|---|---|---|
| Nov 2025 | 0 | 5 |
| Dec 2025 | 0 | 0 |
| Jan 2026 | 3 | 5 |
| Feb 2026 | 0 | 10 |
| Mar 2026 | 0 | 0 |
| Apr 2026 | 0 | 0 |
| May 2026 | 0 | 0 |
| Jun 2026 | 0 | 0 |
| Jul 2026 | 0 | 0 |
| Aug 2026 | 3 | 0 |
| Sep 2026 | 0 | 0 |
| Oct 2026 | 0 | 0 |
Latest available
Insider transactions
Purchases/sales include open-market and private transactions. Plan disclosure applies to the filing; individual rows may differ. “Not disclosed” is not “unplanned.”
The cutoff filters transaction history only. Company summaries and owner relationships show the latest available disclosures. Parser corrections can improve historical records.
| Transaction date | Owner / reported role | Activity / security | Shares / units | Reported price | Reported value | Details |
|---|---|---|---|---|---|---|
| November 08, 2022 Filed Nov 11, 2022 02:02 UTC |
Pestano Gary AnthonyChief Development Officer
|
Exercise / conversionRestricted Stock Units · Derivative | 1,378 | $0.00 | $0.00 |
DisclosureSEC source: 0001140361-22-041078 · form4.xml · derivative · entry 4 Pestano Gary Anthony · CIK 0001827711 · Chief Development Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 17,917 Underlying: Common Stock · 1,378 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · derivative.exercise_price: Each restricted stock unit ("RSU") represents a contingent right to receive one share of Issuer common stock (each, a "Share"). F2 · derivative.exercise_date: These RSUs vest in a series of sixteen successive quarterly installments measured from February 8, 2022, generally subject to the reporting person's continued service with the Issuer, and have no expiration date. F2 · derivative.expiration_date: These RSUs vest in a series of sixteen successive quarterly installments measured from February 8, 2022, generally subject to the reporting person's continued service with the Issuer, and have no expiration date. Read SEC document |
| November 08, 2022 Filed Nov 11, 2022 02:02 UTC |
Pestano Gary AnthonyChief Development Officer
|
Exercise / conversionCommon Stock | 5,054 | Not disclosed | Not disclosed |
DisclosureSEC source: 0001140361-22-041078 · form4.xml · nonDerivative · entry 1 Pestano Gary Anthony · CIK 0001827711 · Chief Development Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 94,312 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · price: Each restricted stock unit ("RSU") represents a contingent right to receive one share of Issuer common stock (each, a "Share"). Read SEC document |
| August 09, 2022 Filed Aug 10, 2022 18:54 UTC |
Hutton ScottDirector · President & CEO
|
SaleCommon Stock | 13,634 | $2.53 | $34,469.48 |
DisclosureSEC source: 0001140361-22-029138 · form4.xml · nonDerivative · entry 2 Hutton Scott · CIK 0001697361 · Director · President & CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 75,009 F4 · kind: These Shares were sold automatically to cover taxes upon the vesting of RSUs. F5 · price: The price reported in Column 4 is a weighted average price of all shares sold on the transaction date by the Issuer's broker to cover taxes upon the vesting of RSUs for certain employees of the Issuer, including the Reporting Person. These shares were sold in multiple transactions at prices ranging from $2.38 to $2.89, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote. Read SEC document |
| August 09, 2022 Filed Aug 10, 2022 22:53 UTC |
Pestano Gary AnthonyChief Development Officer
|
SaleCommon Stock | 1,549 | $2.53 | $3,916.18 |
DisclosureSEC source: 0001140361-22-029134 · form4.xml · nonDerivative · entry 2 Pestano Gary Anthony · CIK 0001827711 · Chief Development Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 89,258 F4 · kind: These Shares were sold automatically to cover taxes upon the vesting of RSUs. F5 · price: The price reported in Column 4 is a weighted average price of all shares sold on the transaction date by the Issuer's broker to cover taxes upon the vesting of RSUs for certain employees of the Issuer, including the Reporting Person. These shares were sold in multiple transactions at prices ranging from $2.38 to $2.89, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote. Read SEC document |
| August 09, 2022 Filed Aug 10, 2022 22:54 UTC |
Siurek Ryan HChief Accounting Officer
|
SaleCommon Stock | 1,645 | $2.53 | $4,158.89 |
DisclosureSEC source: 0001140361-22-029136 · form4.xml · nonDerivative · entry 2 Siurek Ryan H · CIK 0001476512 · Chief Accounting Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 11,242 F4 · kind: These Shares were sold automatically to cover taxes upon the vesting of RSUs. F5 · price: The price reported in Column 4 is a weighted average price of all shares sold on the transaction date by the Issuer's broker to cover taxes upon the vesting of RSUs for certain employees of the Issuer, including the Reporting Person. These shares were sold in multiple transactions at prices ranging from $2.38 to $2.89, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote. Read SEC document |
| August 09, 2022 Filed Aug 10, 2022 22:54 UTC |
Georgantas Robert William IIIChief Scientific Officer
|
SaleCommon Stock | 1,686 | $2.53 | $4,262.55 |
DisclosureSEC source: 0001140361-22-029135 · form4.xml · nonDerivative · entry 2 Georgantas Robert William III · CIK 0001827728 · Chief Scientific Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 22,244 F4 · kind: These Shares were sold automatically to cover taxes upon the vesting of RSUs. F5 · price: The price reported in Column 4 is a weighted average price of all shares sold on the transaction date by the Issuer's broker to cover taxes upon the vesting of RSUs for certain employees of the Issuer, including the Reporting Person. These shares were sold in multiple transactions at prices ranging from $2.38 to $2.89, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote. Read SEC document |
| August 09, 2022 Filed Aug 10, 2022 22:53 UTC |
Cowie Robin HarperCFO, Sec'y & Treasurer
|
SaleCommon Stock | 3,533 | $2.53 | $8,932.13 |
DisclosureSEC source: 0001140361-22-029137 · form4.xml · nonDerivative · entry 2 Cowie Robin Harper · CIK 0001827690 · CFO, Sec'y & Treasurer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 66,537 F4 · kind: These Shares were sold automatically to cover taxes upon the vesting of RSUs. F5 · price: The price reported in Column 4 is a weighted average price of all shares sold on the transaction date by the Issuer's broker to cover taxes upon the vesting of RSUs for certain employees of the Issuer, including the Reporting Person. These shares were sold in multiple transactions at prices ranging from $2.38 to $2.89, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote. Read SEC document |
| August 09, 2022 Filed Aug 10, 2022 22:53 UTC |
O'Kane KieranChief Commercial Officer
|
SaleCommon Stock | 1,673 | $2.53 | $4,229.68 |
DisclosureSEC source: 0001140361-22-029133 · form4.xml · nonDerivative · entry 2 O'Kane Kieran · CIK 0001828131 · Chief Commercial Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 11,428 F4 · kind: These Shares were sold automatically to cover taxes upon the vesting of RSUs. F5 · price: The price reported in Column 4 is a weighted average price of all shares sold on the transaction date by the Issuer's broker to cover taxes upon the vesting of RSUs for certain employees of the Issuer, including the Reporting Person. These shares were sold in multiple transactions at prices ranging from $2.38 to $2.89, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote. Read SEC document |
| August 08, 2022 Filed Aug 10, 2022 18:54 UTC |
Hutton ScottDirector · President & CEO
|
Exercise / conversionRestricted Stock Units · Derivative | 32,565 | $0.00 | $0.00 |
DisclosureSEC source: 0001140361-22-029138 · form4.xml · derivative · entry 4 Hutton Scott · CIK 0001697361 · Director · President & CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 130,262 Underlying: Common Stock · 32,565 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · derivative.exercise_price: Each restricted stock unit ("RSU") represents a contingent right to receive one share of Issuer common stock (each, a "Share"). F3 · derivative.exercise_date: These RSUs vest in a series of six successive quarterly installments from February 8, 2022, generally subject to the reporting person's continued service with the Issuer, and have no expiration date. F3 · derivative.expiration_date: These RSUs vest in a series of six successive quarterly installments from February 8, 2022, generally subject to the reporting person's continued service with the Issuer, and have no expiration date. Read SEC document |
| August 08, 2022 Filed Aug 10, 2022 18:54 UTC |
Hutton ScottDirector · President & CEO
|
Exercise / conversionRestricted Stock Units · Derivative | 12,212 | $0.00 | $0.00 |
DisclosureSEC source: 0001140361-22-029138 · form4.xml · derivative · entry 3 Hutton Scott · CIK 0001697361 · Director · President & CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 170,968 Underlying: Common Stock · 12,212 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · derivative.exercise_price: Each restricted stock unit ("RSU") represents a contingent right to receive one share of Issuer common stock (each, a "Share"). F2 · derivative.exercise_date: These RSUs vest in a series of sixteen successive quarterly installments measured from February 8, 2022, generally subject to the reporting person's continued service with the Issuer, and have no expiration date. F2 · derivative.expiration_date: These RSUs vest in a series of sixteen successive quarterly installments measured from February 8, 2022, generally subject to the reporting person's continued service with the Issuer, and have no expiration date. Read SEC document |
| August 08, 2022 Filed Aug 10, 2022 18:54 UTC |
Hutton ScottDirector · President & CEO
|
Exercise / conversionCommon Stock | 44,777 | Not disclosed | Not disclosed |
DisclosureSEC source: 0001140361-22-029138 · form4.xml · nonDerivative · entry 1 Hutton Scott · CIK 0001697361 · Director · President & CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 88,643 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · price: Each restricted stock unit ("RSU") represents a contingent right to receive one share of Issuer common stock (each, a "Share"). Read SEC document |
| August 08, 2022 Filed Aug 10, 2022 22:53 UTC |
Pestano Gary AnthonyChief Development Officer
|
Exercise / conversionRestricted Stock Units · Derivative | 3,675 | $0.00 | $0.00 |
DisclosureSEC source: 0001140361-22-029134 · form4.xml · derivative · entry 4 Pestano Gary Anthony · CIK 0001827711 · Chief Development Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 14,702 Underlying: Common Stock · 3,675 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · derivative.exercise_price: Each restricted stock unit ("RSU") represents a contingent right to receive one share of Issuer common stock (each, a "Share"). F3 · derivative.exercise_date: These RSUs vest in a series of six successive quarterly installments from February 8, 2022, generally subject to the reporting person's continued service with the Issuer, and have no expiration date. F3 · derivative.expiration_date: These RSUs vest in a series of six successive quarterly installments from February 8, 2022, generally subject to the reporting person's continued service with the Issuer, and have no expiration date. Read SEC document |
| August 08, 2022 Filed Aug 10, 2022 22:53 UTC |
Pestano Gary AnthonyChief Development Officer
|
Exercise / conversionRestricted Stock Units · Derivative | 1,379 | $0.00 | $0.00 |
DisclosureSEC source: 0001140361-22-029134 · form4.xml · derivative · entry 3 Pestano Gary Anthony · CIK 0001827711 · Chief Development Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 19,295 Underlying: Common Stock · 1,379 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · derivative.exercise_price: Each restricted stock unit ("RSU") represents a contingent right to receive one share of Issuer common stock (each, a "Share"). F2 · derivative.exercise_date: These RSUs vest in a series of sixteen successive quarterly installments measured from February 8, 2022, generally subject to the reporting person's continued service with the Issuer, and have no expiration date. F2 · derivative.expiration_date: These RSUs vest in a series of sixteen successive quarterly installments measured from February 8, 2022, generally subject to the reporting person's continued service with the Issuer, and have no expiration date. Read SEC document |
| August 08, 2022 Filed Aug 10, 2022 22:53 UTC |
Pestano Gary AnthonyChief Development Officer
|
Exercise / conversionCommon Stock | 5,054 | Not disclosed | Not disclosed |
DisclosureSEC source: 0001140361-22-029134 · form4.xml · nonDerivative · entry 1 Pestano Gary Anthony · CIK 0001827711 · Chief Development Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 90,807 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · price: Each restricted stock unit ("RSU") represents a contingent right to receive one share of Issuer common stock (each, a "Share"). Read SEC document |
| August 08, 2022 Filed Aug 10, 2022 22:54 UTC |
Siurek Ryan HChief Accounting Officer
|
Exercise / conversionRestricted Stock Units · Derivative | 3,557 | $0.00 | $0.00 |
DisclosureSEC source: 0001140361-22-029136 · form4.xml · derivative · entry 4 Siurek Ryan H · CIK 0001476512 · Chief Accounting Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 14,227 Underlying: Common Stock · 3,557 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · derivative.exercise_price: Each restricted stock unit ("RSU") represents a contingent right to receive one share of Issuer common stock (each, a "Share"). F3 · derivative.exercise_date: These RSUs vest in a series of six successive quarterly installments from February 8, 2022, generally subject to the reporting person's continued service with the Issuer, and have no expiration date. F3 · derivative.expiration_date: These RSUs vest in a series of six successive quarterly installments from February 8, 2022, generally subject to the reporting person's continued service with the Issuer, and have no expiration date. Read SEC document |
| August 08, 2022 Filed Aug 10, 2022 22:54 UTC |
Siurek Ryan HChief Accounting Officer
|
Exercise / conversionRestricted Stock Units · Derivative | 1,927 | $0.00 | $0.00 |
DisclosureSEC source: 0001140361-22-029136 · form4.xml · derivative · entry 3 Siurek Ryan H · CIK 0001476512 · Chief Accounting Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 26,972 Underlying: Common Stock · 1,927 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · derivative.exercise_price: Each restricted stock unit ("RSU") represents a contingent right to receive one share of Issuer common stock (each, a "Share"). F2 · derivative.exercise_date: These RSUs vest in a series of sixteen successive quarterly installments measured from February 8, 2022, generally subject to the reporting person's continued service with the Issuer, and have no expiration date. F2 · derivative.expiration_date: These RSUs vest in a series of sixteen successive quarterly installments measured from February 8, 2022, generally subject to the reporting person's continued service with the Issuer, and have no expiration date. Read SEC document |
| August 08, 2022 Filed Aug 10, 2022 22:54 UTC |
Siurek Ryan HChief Accounting Officer
|
Exercise / conversionCommon Stock | 5,484 | Not disclosed | Not disclosed |
DisclosureSEC source: 0001140361-22-029136 · form4.xml · nonDerivative · entry 1 Siurek Ryan H · CIK 0001476512 · Chief Accounting Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 12,887 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · price: Each restricted stock unit ("RSU") represents a contingent right to receive one share of Issuer common stock (each, a "Share"). Read SEC document |
| August 08, 2022 Filed Aug 10, 2022 22:54 UTC |
Georgantas Robert William IIIChief Scientific Officer
|
Exercise / conversionRestricted Stock Units · Derivative | 3,675 | $0.00 | $0.00 |
DisclosureSEC source: 0001140361-22-029135 · form4.xml · derivative · entry 5 Georgantas Robert William III · CIK 0001827728 · Chief Scientific Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 14,702 Underlying: Common Stock · 3,675 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · derivative.exercise_price: Each restricted stock unit ("RSU") represents a contingent right to receive one share of Issuer common stock (each, a "Share"). F3 · derivative.exercise_date: These RSUs vest in a series of six successive quarterly installments from February 8, 2022, generally subject to the reporting person's continued service with the Issuer, and have no expiration date. F3 · derivative.expiration_date: These RSUs vest in a series of six successive quarterly installments from February 8, 2022, generally subject to the reporting person's continued service with the Issuer, and have no expiration date. Read SEC document |
| August 08, 2022 Filed Aug 10, 2022 22:54 UTC |
Georgantas Robert William IIIChief Scientific Officer
|
Exercise / conversionRestricted Stock Units · Derivative | 1,972 | $0.00 | $0.00 |
DisclosureSEC source: 0001140361-22-029135 · form4.xml · derivative · entry 4 Georgantas Robert William III · CIK 0001827728 · Chief Scientific Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 27,594 Underlying: Common Stock · 1,972 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · derivative.exercise_price: Each restricted stock unit ("RSU") represents a contingent right to receive one share of Issuer common stock (each, a "Share"). F2 · derivative.exercise_date: These RSUs vest in a series of sixteen successive quarterly installments measured from February 8, 2022, generally subject to the reporting person's continued service with the Issuer, and have no expiration date. F2 · derivative.expiration_date: These RSUs vest in a series of sixteen successive quarterly installments measured from February 8, 2022, generally subject to the reporting person's continued service with the Issuer, and have no expiration date. Read SEC document |
| August 08, 2022 Filed Aug 10, 2022 22:54 UTC |
Georgantas Robert William IIIChief Scientific Officer
|
Exercise / conversionCommon Stock | 5,647 | Not disclosed | Not disclosed |
DisclosureSEC source: 0001140361-22-029135 · form4.xml · nonDerivative · entry 1 Georgantas Robert William III · CIK 0001827728 · Chief Scientific Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 23,930 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · price: Each restricted stock unit ("RSU") represents a contingent right to receive one share of Issuer common stock (each, a "Share"). Read SEC document |
| August 08, 2022 Filed Aug 10, 2022 22:53 UTC |
Cowie Robin HarperCFO, Sec'y & Treasurer
|
Exercise / conversionRestricted Stock Units · Derivative | 8,418 | $0.00 | $0.00 |
DisclosureSEC source: 0001140361-22-029137 · form4.xml · derivative · entry 4 Cowie Robin Harper · CIK 0001827690 · CFO, Sec'y & Treasurer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 33,672 Underlying: Common Stock · 8,418 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · derivative.exercise_price: Each restricted stock unit ("RSU") represents a contingent right to receive one share of Issuer common stock (each, a "Share"). F3 · derivative.exercise_date: These RSUs vest in a series of six successive quarterly installments from February 8, 2022, generally subject to the reporting person's continued service with the Issuer, and have no expiration date. F3 · derivative.expiration_date: These RSUs vest in a series of six successive quarterly installments from February 8, 2022, generally subject to the reporting person's continued service with the Issuer, and have no expiration date. Read SEC document |
| August 08, 2022 Filed Aug 10, 2022 22:53 UTC |
Cowie Robin HarperCFO, Sec'y & Treasurer
|
Exercise / conversionRestricted Stock Units · Derivative | 3,157 | $0.00 | $0.00 |
DisclosureSEC source: 0001140361-22-029137 · form4.xml · derivative · entry 3 Cowie Robin Harper · CIK 0001827690 · CFO, Sec'y & Treasurer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 44,194 Underlying: Common Stock · 3,157 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · derivative.exercise_price: Each restricted stock unit ("RSU") represents a contingent right to receive one share of Issuer common stock (each, a "Share"). F2 · derivative.exercise_date: These RSUs vest in a series of sixteen successive quarterly installments measured from February 8, 2022, generally subject to the reporting person's continued service with the Issuer, and have no expiration date. F2 · derivative.expiration_date: These RSUs vest in a series of sixteen successive quarterly installments measured from February 8, 2022, generally subject to the reporting person's continued service with the Issuer, and have no expiration date. Read SEC document |
| August 08, 2022 Filed Aug 10, 2022 22:53 UTC |
Cowie Robin HarperCFO, Sec'y & Treasurer
|
Exercise / conversionCommon Stock | 11,575 | Not disclosed | Not disclosed |
DisclosureSEC source: 0001140361-22-029137 · form4.xml · nonDerivative · entry 1 Cowie Robin Harper · CIK 0001827690 · CFO, Sec'y & Treasurer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 70,070 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · price: Each restricted stock unit ("RSU") represents a contingent right to receive one share of Issuer common stock (each, a "Share"). Read SEC document |
| August 08, 2022 Filed Aug 10, 2022 22:53 UTC |
O'Kane KieranChief Commercial Officer
|
Exercise / conversionRestricted Stock Units · Derivative | 3,972 | $0.00 | $0.00 |
DisclosureSEC source: 0001140361-22-029133 · form4.xml · derivative · entry 4 O'Kane Kieran · CIK 0001828131 · Chief Commercial Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 15,887 Underlying: Common Stock · 3,972 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · derivative.exercise_price: Each restricted stock unit ("RSU") represents a contingent right to receive one share of Issuer common stock (each, a "Share"). F3 · derivative.exercise_date: These RSUs vest in a series of six successive quarterly installments from February 8, 2022, generally subject to the reporting person's continued service with the Issuer, and have no expiration date. F3 · derivative.expiration_date: These RSUs vest in a series of six successive quarterly installments from February 8, 2022, generally subject to the reporting person's continued service with the Issuer, and have no expiration date. Read SEC document |
| August 08, 2022 Filed Aug 10, 2022 22:53 UTC |
O'Kane KieranChief Commercial Officer
|
Exercise / conversionRestricted Stock Units · Derivative | 1,490 | $0.00 | $0.00 |
DisclosureSEC source: 0001140361-22-029133 · form4.xml · derivative · entry 3 O'Kane Kieran · CIK 0001828131 · Chief Commercial Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 20,852 Underlying: Common Stock · 1,490 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · derivative.exercise_price: Each restricted stock unit ("RSU") represents a contingent right to receive one share of Issuer common stock (each, a "Share"). F2 · derivative.exercise_date: These RSUs vest in a series of sixteen successive quarterly installments measured from February 8, 2022, generally subject to the reporting person's continued service with the Issuer, and have no expiration date. F2 · derivative.expiration_date: These RSUs vest in a series of sixteen successive quarterly installments measured from February 8, 2022, generally subject to the reporting person's continued service with the Issuer, and have no expiration date. Read SEC document |
| August 08, 2022 Filed Aug 10, 2022 22:53 UTC |
O'Kane KieranChief Commercial Officer
|
Exercise / conversionCommon Stock | 5,462 | Not disclosed | Not disclosed |
DisclosureSEC source: 0001140361-22-029133 · form4.xml · nonDerivative · entry 1 O'Kane Kieran · CIK 0001828131 · Chief Commercial Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 13,101 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · price: Each restricted stock unit ("RSU") represents a contingent right to receive one share of Issuer common stock (each, a "Share"). Read SEC document |
| May 24, 2022 Filed May 26, 2022 20:15 UTC |
SCHULER JACK WDirector · 10% owner
|
GrantRestricted Stock Units · Derivative | 83,333 | $0.00 | $0.00 |
DisclosureSEC source: 0001140361-22-020786 · form4.xml · derivative · entry 1 SCHULER JACK W · CIK 0001021412 · Director · 10% owner 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 83,333 Underlying: Common Stock · 83,333 shares Expires not disclosed F1 · derivative.exercise_price: Each restricted stock unit ("RSU") represents a contingent right to receive one share of Issuer common stock and has no expiration date. F3 · shares: The Compensation Committee of the Issuer's Board of Directors also approved a grant to the Reporting Person, effective January 1, 2023, of an additional 62,500 RSUs that will vest in full on March 31, 2023, generally subject to the reporting person's continued service with the Issuer. In the event the reporting person's continued service on the Board terminates other than for cause, the option will vest on a prorated basis based on the number of full months of service the reporting person completed during the applicable vesting period. F2 · derivative.exercise_date: These RSUs will vest in full on March 31, 2023, generally subject to the reporting person's continued service with the Issuer. In the event the reporting person's continued service on the Board terminates other than for cause, the option will vest on a prorated basis based on the number of full months of service the reporting person completed during the applicable vesting period. F2 · derivative.expiration_date: These RSUs will vest in full on March 31, 2023, generally subject to the reporting person's continued service with the Issuer. In the event the reporting person's continued service on the Board terminates other than for cause, the option will vest on a prorated basis based on the number of full months of service the reporting person completed during the applicable vesting period. F3 · derivative.underlying_shares: The Compensation Committee of the Issuer's Board of Directors also approved a grant to the Reporting Person, effective January 1, 2023, of an additional 62,500 RSUs that will vest in full on March 31, 2023, generally subject to the reporting person's continued service with the Issuer. In the event the reporting person's continued service on the Board terminates other than for cause, the option will vest on a prorated basis based on the number of full months of service the reporting person completed during the applicable vesting period. F3 · balance_after: The Compensation Committee of the Issuer's Board of Directors also approved a grant to the Reporting Person, effective January 1, 2023, of an additional 62,500 RSUs that will vest in full on March 31, 2023, generally subject to the reporting person's continued service with the Issuer. In the event the reporting person's continued service on the Board terminates other than for cause, the option will vest on a prorated basis based on the number of full months of service the reporting person completed during the applicable vesting period. Read SEC document |
| May 24, 2022 Filed May 26, 2022 20:15 UTC |
PATIENCE JOHNDirector · 10% owner · Chairman
|
GrantRestricted Stock Units · Derivative | 83,333 | $0.00 | $0.00 |
DisclosureSEC source: 0001140361-22-020782 · form4.xml · derivative · entry 1 PATIENCE JOHN · CIK 0001021413 · Director · 10% owner · Chairman 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 83,333 Underlying: Common Stock · 83,333 shares Expires not disclosed F1 · derivative.exercise_price: Each restricted stock unit ("RSU") represents a contingent right to receive one share of Issuer common stock and has no expiration date. F3 · shares: The Compensation Committee of the Issuer's Board of Directors also approved a grant to the Reporting Person, effective January 1, 2023, of an additional 62,500 RSUs that will vest in full on March 31, 2023, generally subject to the reporting person's continued service with the Issuer. In the event the reporting person's continued service on the Board terminates other than for cause, the option will vest on a prorated basis based on the number of full months of service the reporting person completed during the applicable vesting period. F2 · derivative.exercise_date: These RSUs will vest in full on March 31, 2023, generally subject to the reporting person's continued service with the Issuer. In the event the reporting person's continued service on the Board terminates other than for cause, the option will vest on a prorated basis based on the number of full months of service the reporting person completed during the applicable vesting period. F2 · derivative.expiration_date: These RSUs will vest in full on March 31, 2023, generally subject to the reporting person's continued service with the Issuer. In the event the reporting person's continued service on the Board terminates other than for cause, the option will vest on a prorated basis based on the number of full months of service the reporting person completed during the applicable vesting period. F3 · derivative.underlying_shares: The Compensation Committee of the Issuer's Board of Directors also approved a grant to the Reporting Person, effective January 1, 2023, of an additional 62,500 RSUs that will vest in full on March 31, 2023, generally subject to the reporting person's continued service with the Issuer. In the event the reporting person's continued service on the Board terminates other than for cause, the option will vest on a prorated basis based on the number of full months of service the reporting person completed during the applicable vesting period. F3 · balance_after: The Compensation Committee of the Issuer's Board of Directors also approved a grant to the Reporting Person, effective January 1, 2023, of an additional 62,500 RSUs that will vest in full on March 31, 2023, generally subject to the reporting person's continued service with the Issuer. In the event the reporting person's continued service on the Board terminates other than for cause, the option will vest on a prorated basis based on the number of full months of service the reporting person completed during the applicable vesting period. Read SEC document |
| May 24, 2022 Filed May 26, 2022 16:15 UTC |
MASSARANY HANYDirector
|
GrantRestricted Stock Units · Derivative | 83,333 | $0.00 | $0.00 |
DisclosureSEC source: 0001140361-22-020787 · form4.xml · derivative · entry 1 MASSARANY HANY · CIK 0001134554 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 83,333 Underlying: Common Stock · 83,333 shares Expires not disclosed F1 · derivative.exercise_price: Each restricted stock unit ("RSU") represents a contingent right to receive one share of Issuer common stock and has no expiration date. F3 · shares: The Compensation Committee of the Issuer's Board of Directors also approved a grant to the Reporting Person, effective January 1, 2023, of an additional 62,500 RSUs that will vest in full on March 31, 2023, generally subject to the reporting person's continued service with the Issuer. In the event the reporting person's continued service on the Board terminates other than for cause, the option will vest on a prorated basis based on the number of full months of service the reporting person completed during the applicable vesting period. F2 · derivative.exercise_date: These RSUs will vest in full on March 31, 2023, generally subject to the reporting person's continued service with the Issuer. In the event the reporting person's continued service on the Board terminates other than for cause, the option will vest on a prorated basis based on the number of full months of service the reporting person completed during the applicable vesting period. F2 · derivative.expiration_date: These RSUs will vest in full on March 31, 2023, generally subject to the reporting person's continued service with the Issuer. In the event the reporting person's continued service on the Board terminates other than for cause, the option will vest on a prorated basis based on the number of full months of service the reporting person completed during the applicable vesting period. F3 · derivative.underlying_shares: The Compensation Committee of the Issuer's Board of Directors also approved a grant to the Reporting Person, effective January 1, 2023, of an additional 62,500 RSUs that will vest in full on March 31, 2023, generally subject to the reporting person's continued service with the Issuer. In the event the reporting person's continued service on the Board terminates other than for cause, the option will vest on a prorated basis based on the number of full months of service the reporting person completed during the applicable vesting period. F3 · balance_after: The Compensation Committee of the Issuer's Board of Directors also approved a grant to the Reporting Person, effective January 1, 2023, of an additional 62,500 RSUs that will vest in full on March 31, 2023, generally subject to the reporting person's continued service with the Issuer. In the event the reporting person's continued service on the Board terminates other than for cause, the option will vest on a prorated basis based on the number of full months of service the reporting person completed during the applicable vesting period. Read SEC document |
| May 24, 2022 Filed May 26, 2022 16:16 UTC |
Watts Charles MDirector
|
GrantRestricted Stock Units · Derivative | 83,333 | $0.00 | $0.00 |
DisclosureSEC source: 0001140361-22-020789 · form4.xml · derivative · entry 1 Watts Charles M · CIK 0001723751 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 83,333 Underlying: Common Stock · 83,333 shares Expires not disclosed F1 · derivative.exercise_price: Each restricted stock unit ("RSU") represents a contingent right to receive one share of Issuer common stock and has no expiration date. F3 · shares: The Compensation Committee of the Issuer's Board of Directors also approved a grant to the Reporting Person, effective January 1, 2023, of an additional 62,500 RSUs that will vest in full on March 31, 2023, generally subject to the reporting person's continued service with the Issuer. In the event the reporting person's continued service on the Board terminates other than for cause, the option will vest on a prorated basis based on the number of full months of service the reporting person completed during the applicable vesting period. F2 · derivative.exercise_date: These RSUs will vest in full on March 31, 2023, generally subject to the reporting person's continued service with the Issuer. In the event the reporting person's continued service on the Board terminates other than for cause, the option will vest on a prorated basis based on the number of full months of service the reporting person completed during the applicable vesting period. F2 · derivative.expiration_date: These RSUs will vest in full on March 31, 2023, generally subject to the reporting person's continued service with the Issuer. In the event the reporting person's continued service on the Board terminates other than for cause, the option will vest on a prorated basis based on the number of full months of service the reporting person completed during the applicable vesting period. F3 · derivative.underlying_shares: The Compensation Committee of the Issuer's Board of Directors also approved a grant to the Reporting Person, effective January 1, 2023, of an additional 62,500 RSUs that will vest in full on March 31, 2023, generally subject to the reporting person's continued service with the Issuer. In the event the reporting person's continued service on the Board terminates other than for cause, the option will vest on a prorated basis based on the number of full months of service the reporting person completed during the applicable vesting period. F3 · balance_after: The Compensation Committee of the Issuer's Board of Directors also approved a grant to the Reporting Person, effective January 1, 2023, of an additional 62,500 RSUs that will vest in full on March 31, 2023, generally subject to the reporting person's continued service with the Issuer. In the event the reporting person's continued service on the Board terminates other than for cause, the option will vest on a prorated basis based on the number of full months of service the reporting person completed during the applicable vesting period. Read SEC document |
| May 24, 2022 Filed May 26, 2022 20:16 UTC |
Strobeck MatthewDirector
|
GrantRestricted Stock Units · Derivative | 83,333 | $0.00 | $0.00 |
DisclosureSEC source: 0001140361-22-020788 · form4.xml · derivative · entry 1 Strobeck Matthew · CIK 0001377832 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 83,333 Underlying: Common Stock · 83,333 shares Expires not disclosed F1 · derivative.exercise_price: Each restricted stock unit ("RSU") represents a contingent right to receive one share of Issuer common stock and has no expiration date. F3 · shares: The Compensation Committee of the Issuer's Board of Directors also approved a grant to the Reporting Person, effective January 1, 2023, of an additional 62,500 RSUs that will vest in full on March 31, 2023, generally subject to the reporting person's continued service with the Issuer. In the event the reporting person's continued service on the Board terminates other than for cause, the option will vest on a prorated basis based on the number of full months of service the reporting person completed during the applicable vesting period. F2 · derivative.exercise_date: These RSUs will vest in full on March 31, 2023, generally subject to the reporting person's continued service with the Issuer. In the event the reporting person's continued service on the Board terminates other than for cause, the option will vest on a prorated basis based on the number of full months of service the reporting person completed during the applicable vesting period. F2 · derivative.expiration_date: These RSUs will vest in full on March 31, 2023, generally subject to the reporting person's continued service with the Issuer. In the event the reporting person's continued service on the Board terminates other than for cause, the option will vest on a prorated basis based on the number of full months of service the reporting person completed during the applicable vesting period. F3 · derivative.underlying_shares: The Compensation Committee of the Issuer's Board of Directors also approved a grant to the Reporting Person, effective January 1, 2023, of an additional 62,500 RSUs that will vest in full on March 31, 2023, generally subject to the reporting person's continued service with the Issuer. In the event the reporting person's continued service on the Board terminates other than for cause, the option will vest on a prorated basis based on the number of full months of service the reporting person completed during the applicable vesting period. F3 · balance_after: The Compensation Committee of the Issuer's Board of Directors also approved a grant to the Reporting Person, effective January 1, 2023, of an additional 62,500 RSUs that will vest in full on March 31, 2023, generally subject to the reporting person's continued service with the Issuer. In the event the reporting person's continued service on the Board terminates other than for cause, the option will vest on a prorated basis based on the number of full months of service the reporting person completed during the applicable vesting period. Read SEC document |
| May 24, 2022 Filed May 26, 2022 20:15 UTC |
Kayyem Jon FaizDirector
|
GrantRestricted Stock Units · Derivative | 83,333 | $0.00 | $0.00 |
DisclosureSEC source: 0001140361-22-020784 · form4.xml · derivative · entry 1 Kayyem Jon Faiz · CIK 0001366268 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 83,333 Underlying: Common Stock · 83,333 shares Expires not disclosed F1 · derivative.exercise_price: Each restricted stock unit ("RSU") represents a contingent right to receive one share of Issuer common stock and has no expiration date. F3 · shares: The Compensation Committee of the Issuer's Board of Directors also approved a grant to the Reporting Person, effective January 1, 2023, of an additional 62,500 RSUs that will vest in full on March 31, 2023, generally subject to the reporting person's continued service with the Issuer. In the event the reporting person's continued service on the Board terminates other than for cause, the option will vest on a prorated basis based on the number of full months of service the reporting person completed during the applicable vesting period. F2 · derivative.exercise_date: These RSUs will vest in full on March 31, 2023, generally subject to the reporting person's continued service with the Issuer. In the event the reporting person's continued service on the Board terminates other than for cause, the option will vest on a prorated basis based on the number of full months of service the reporting person completed during the applicable vesting period. F2 · derivative.expiration_date: These RSUs will vest in full on March 31, 2023, generally subject to the reporting person's continued service with the Issuer. In the event the reporting person's continued service on the Board terminates other than for cause, the option will vest on a prorated basis based on the number of full months of service the reporting person completed during the applicable vesting period. F3 · derivative.underlying_shares: The Compensation Committee of the Issuer's Board of Directors also approved a grant to the Reporting Person, effective January 1, 2023, of an additional 62,500 RSUs that will vest in full on March 31, 2023, generally subject to the reporting person's continued service with the Issuer. In the event the reporting person's continued service on the Board terminates other than for cause, the option will vest on a prorated basis based on the number of full months of service the reporting person completed during the applicable vesting period. F3 · balance_after: The Compensation Committee of the Issuer's Board of Directors also approved a grant to the Reporting Person, effective January 1, 2023, of an additional 62,500 RSUs that will vest in full on March 31, 2023, generally subject to the reporting person's continued service with the Issuer. In the event the reporting person's continued service on the Board terminates other than for cause, the option will vest on a prorated basis based on the number of full months of service the reporting person completed during the applicable vesting period. Read SEC document |
| May 24, 2022 Filed May 26, 2022 20:15 UTC |
Franchi Jean M.Director
|
GrantRestricted Stock Units · Derivative | 83,333 | $0.00 | $0.00 |
DisclosureSEC source: 0001140361-22-020780 · form4.xml · derivative · entry 1 Franchi Jean M. · CIK 0001653053 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 83,333 Underlying: Common Stock · 83,333 shares Expires not disclosed F1 · derivative.exercise_price: Each restricted stock unit ("RSU") represents a contingent right to receive one share of Issuer common stock and has no expiration date. F3 · shares: The Compensation Committee of the Issuer's Board of Directors also approved a grant to the Reporting Person, effective January 1, 2023, of an additional 62,500 RSUs that will vest in full on March 31, 2023, generally subject to the reporting person's continued service with the Issuer. In the event the reporting person's continued service on the Board terminates other than for cause, the option will vest on a prorated basis based on the number of full months of service the reporting person completed during the applicable vesting period. F2 · derivative.exercise_date: These RSUs will vest in full on March 31, 2023, generally subject to the reporting person's continued service with the Issuer. In the event the reporting person's continued service on the Board terminates other than for cause, the option will vest on a prorated basis based on the number of full months of service the reporting person completed during the applicable vesting period. F2 · derivative.expiration_date: These RSUs will vest in full on March 31, 2023, generally subject to the reporting person's continued service with the Issuer. In the event the reporting person's continued service on the Board terminates other than for cause, the option will vest on a prorated basis based on the number of full months of service the reporting person completed during the applicable vesting period. F3 · derivative.underlying_shares: The Compensation Committee of the Issuer's Board of Directors also approved a grant to the Reporting Person, effective January 1, 2023, of an additional 62,500 RSUs that will vest in full on March 31, 2023, generally subject to the reporting person's continued service with the Issuer. In the event the reporting person's continued service on the Board terminates other than for cause, the option will vest on a prorated basis based on the number of full months of service the reporting person completed during the applicable vesting period. F3 · balance_after: The Compensation Committee of the Issuer's Board of Directors also approved a grant to the Reporting Person, effective January 1, 2023, of an additional 62,500 RSUs that will vest in full on March 31, 2023, generally subject to the reporting person's continued service with the Issuer. In the event the reporting person's continued service on the Board terminates other than for cause, the option will vest on a prorated basis based on the number of full months of service the reporting person completed during the applicable vesting period. Read SEC document |
| May 10, 2022 Filed May 11, 2022 21:41 UTC |
Hutton ScottDirector · President & CEO
|
SaleCommon Stock | 13,278 | $1.83 | $24,298.74 |
DisclosureSEC source: 0001140361-22-018733 · form4.xml · nonDerivative · entry 2 Hutton Scott · CIK 0001697361 · Director · President & CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 43,866 F4 · kind: These Shares were sold automatically to cover taxes upon the vesting of RSUs. F5 · price: The price reported in Column 4 is a weighted average price of all shares sold on the transaction date by the Issuer's broker to cover taxes upon the vesting of RSUs for certain employees of the Issuer, including the Reporting Person. These shares were sold in multiple transactions at prices ranging from $1.73 to $1.945, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote. Read SEC document |
| May 10, 2022 Filed May 12, 2022 01:42 UTC |
Siurek Ryan HChief Accounting Officer
|
SaleCommon Stock | 1,947 | $1.83 | $3,563.01 |
DisclosureSEC source: 0001140361-22-018735 · form4.xml · nonDerivative · entry 2 Siurek Ryan H · CIK 0001476512 · Chief Accounting Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 7,403 F4 · kind: These Shares were sold automatically to cover taxes upon the vesting of RSUs. F5 · price: The price reported in Column 4 is a weighted average price of all shares sold on the transaction date by the Issuer's broker to cover taxes upon the vesting of RSUs for certain employees of the Issuer, including the Reporting Person. These shares were sold in multiple transactions at prices ranging from $1.73 to $1.945, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote. Read SEC document |
| May 10, 2022 Filed May 12, 2022 01:42 UTC |
Georgantas Robert William IIIChief Scientific Officer
|
SaleCommon Stock | 2,004 | $1.83 | $3,667.32 |
DisclosureSEC source: 0001140361-22-018734 · form4.xml · nonDerivative · entry 2 Georgantas Robert William III · CIK 0001827728 · Chief Scientific Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 18,283 F4 · kind: These Shares were sold automatically to cover taxes upon the vesting of RSUs. F5 · price: The price reported in Column 4 is a weighted average price of all shares sold on the transaction date by the Issuer's broker to cover taxes upon the vesting of RSUs for certain employees of the Issuer, including the Reporting Person. These shares were sold in multiple transactions at prices ranging from $1.73 to $1.945, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote. Read SEC document |
| May 10, 2022 Filed May 12, 2022 01:42 UTC |
O'Kane KieranChief Commercial Officer
|
SaleCommon Stock | 1,583 | $1.83 | $2,896.89 |
DisclosureSEC source: 0001140361-22-018736 · form4.xml · nonDerivative · entry 2 O'Kane Kieran · CIK 0001828131 · Chief Commercial Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 7,639 F4 · kind: These Shares were sold automatically to cover taxes upon the vesting of RSUs. F5 · price: The price reported in Column 4 is a weighted average price of all shares sold on the transaction date by the Issuer's broker to cover taxes upon the vesting of RSUs for certain employees of the Issuer, including the Reporting Person. These shares were sold in multiple transactions at prices ranging from $1.73 to $1.945, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote. Read SEC document |
| May 10, 2022 Filed May 12, 2022 01:41 UTC |
Pestano Gary AnthonyChief Development Officer
|
SaleCommon Stock | 1,467 | $1.83 | $2,684.61 |
DisclosureSEC source: 0001140361-22-018732 · form4.xml · nonDerivative · entry 2 Pestano Gary Anthony · CIK 0001827711 · Chief Development Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 85,753 F4 · kind: These Shares were sold automatically to cover taxes upon the vesting of RSUs. F5 · price: The price reported in Column 4 is a weighted average price of all shares sold on the transaction date by the Issuer's broker to cover taxes upon the vesting of RSUs for certain employees of the Issuer, including the Reporting Person. These shares were sold in multiple transactions at prices ranging from $1.73 to $1.945, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote. Read SEC document |
| May 10, 2022 Filed May 12, 2022 01:41 UTC |
Cowie Robin HarperCFO, Sec'y & Treasurer
|
SaleCommon Stock | 3,338 | $1.83 | $6,108.54 |
DisclosureSEC source: 0001140361-22-018731 · form4.xml · nonDerivative · entry 2 Cowie Robin Harper · CIK 0001827690 · CFO, Sec'y & Treasurer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 58,495 F4 · kind: These Shares were sold automatically to cover taxes upon the vesting of RSUs. F5 · price: The price reported in Column 4 is a weighted average price of all shares sold on the transaction date by the Issuer's broker to cover taxes upon the vesting of RSUs for certain employees of the Issuer, including the Reporting Person. These shares were sold in multiple transactions at prices ranging from $1.73 to $1.945, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote. Read SEC document |
| May 09, 2022 Filed May 11, 2022 21:41 UTC |
Hutton ScottDirector · President & CEO
|
Exercise / conversionRestricted Stock Units · Derivative | 32,566 | $0.00 | $0.00 |
DisclosureSEC source: 0001140361-22-018733 · form4.xml · derivative · entry 4 Hutton Scott · CIK 0001697361 · Director · President & CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 162,827 Underlying: Common Stock · 32,566 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · derivative.exercise_price: Each restricted stock unit ("RSU") represents a contingent right to receive one share of Issuer common stock (each, a "Share"). F3 · derivative.exercise_date: These RSUs vest in a series of six successive quarterly installments from February 8, 2022, generally subject to the reporting person's continued service with the Issuer, and have no expiration date. F3 · derivative.expiration_date: These RSUs vest in a series of six successive quarterly installments from February 8, 2022, generally subject to the reporting person's continued service with the Issuer, and have no expiration date. Read SEC document |
| May 09, 2022 Filed May 11, 2022 21:41 UTC |
Hutton ScottDirector · President & CEO
|
Exercise / conversionRestricted Stock Units · Derivative | 12,212 | $0.00 | $0.00 |
DisclosureSEC source: 0001140361-22-018733 · form4.xml · derivative · entry 3 Hutton Scott · CIK 0001697361 · Director · President & CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 183,180 Underlying: Common Stock · 12,212 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · derivative.exercise_price: Each restricted stock unit ("RSU") represents a contingent right to receive one share of Issuer common stock (each, a "Share"). F2 · derivative.exercise_date: These RSUs vest in a series of sixteen successive quarterly installments measured from February 8, 2022, generally subject to the reporting person's continued service with the Issuer, and have no expiration date. F2 · derivative.expiration_date: These RSUs vest in a series of sixteen successive quarterly installments measured from February 8, 2022, generally subject to the reporting person's continued service with the Issuer, and have no expiration date. Read SEC document |
| May 09, 2022 Filed May 11, 2022 21:41 UTC |
Hutton ScottDirector · President & CEO
|
Exercise / conversionCommon Stock | 44,778 | Not disclosed | Not disclosed |
DisclosureSEC source: 0001140361-22-018733 · form4.xml · nonDerivative · entry 1 Hutton Scott · CIK 0001697361 · Director · President & CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 57,144 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · price: Each restricted stock unit ("RSU") represents a contingent right to receive one share of Issuer common stock (each, a "Share"). F6 · balance_after: Includes 2,604 Shares acquired under the BDSX stock purchase plan on February 28, 2022. Read SEC document |
| May 09, 2022 Filed May 12, 2022 01:42 UTC |
Siurek Ryan HChief Accounting Officer
|
Exercise / conversionRestricted Stock Units · Derivative | 3,557 | $0.00 | $0.00 |
DisclosureSEC source: 0001140361-22-018735 · form4.xml · derivative · entry 4 Siurek Ryan H · CIK 0001476512 · Chief Accounting Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 17,784 Underlying: Common Stock · 3,557 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · derivative.exercise_price: Each restricted stock unit ("RSU") represents a contingent right to receive one share of Issuer common stock (each, a "Share"). F3 · derivative.exercise_date: These RSUs vest in a series of six successive quarterly installments from February 8, 2022, generally subject to the reporting person's continued service with the Issuer, and have no expiration date. F3 · derivative.expiration_date: These RSUs vest in a series of six successive quarterly installments from February 8, 2022, generally subject to the reporting person's continued service with the Issuer, and have no expiration date. Read SEC document |
| May 09, 2022 Filed May 12, 2022 01:42 UTC |
Siurek Ryan HChief Accounting Officer
|
Exercise / conversionRestricted Stock Units · Derivative | 1,927 | $0.00 | $0.00 |
DisclosureSEC source: 0001140361-22-018735 · form4.xml · derivative · entry 3 Siurek Ryan H · CIK 0001476512 · Chief Accounting Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 28,899 Underlying: Common Stock · 1,927 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · derivative.exercise_price: Each restricted stock unit ("RSU") represents a contingent right to receive one share of Issuer common stock (each, a "Share"). F2 · derivative.exercise_date: These RSUs vest in a series of sixteen successive quarterly installments measured from February 8, 2022, generally subject to the reporting person's continued service with the Issuer, and have no expiration date. F2 · derivative.expiration_date: These RSUs vest in a series of sixteen successive quarterly installments measured from February 8, 2022, generally subject to the reporting person's continued service with the Issuer, and have no expiration date. Read SEC document |
| May 09, 2022 Filed May 12, 2022 01:42 UTC |
Siurek Ryan HChief Accounting Officer
|
Exercise / conversionCommon Stock | 5,484 | Not disclosed | Not disclosed |
DisclosureSEC source: 0001140361-22-018735 · form4.xml · nonDerivative · entry 1 Siurek Ryan H · CIK 0001476512 · Chief Accounting Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 9,350 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · price: Each restricted stock unit ("RSU") represents a contingent right to receive one share of Issuer common stock (each, a "Share"). F6 · balance_after: Includes 1,262 and 2,604 Shares acquired under the BDSX stock purchase plan on August 31, 2021 and February 28, 2022, respectively. Read SEC document |
| May 09, 2022 Filed May 12, 2022 01:42 UTC |
Georgantas Robert William IIIChief Scientific Officer
|
Exercise / conversionRestricted Stock Units · Derivative | 3,676 | $0.00 | $0.00 |
DisclosureSEC source: 0001140361-22-018734 · form4.xml · derivative · entry 5 Georgantas Robert William III · CIK 0001827728 · Chief Scientific Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 18,377 Underlying: Common Stock · 3,676 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · derivative.exercise_price: Each restricted stock unit ("RSU") represents a contingent right to receive one share of Issuer common stock (each, a "Share"). F3 · derivative.exercise_date: These RSUs vest in a series of six successive quarterly installments from February 8, 2022, generally subject to the reporting person's continued service with the Issuer, and have no expiration date. F3 · derivative.expiration_date: These RSUs vest in a series of six successive quarterly installments from February 8, 2022, generally subject to the reporting person's continued service with the Issuer, and have no expiration date. Read SEC document |
| May 09, 2022 Filed May 12, 2022 01:42 UTC |
Georgantas Robert William IIIChief Scientific Officer
|
Exercise / conversionRestricted Stock Units · Derivative | 1,971 | $0.00 | $0.00 |
DisclosureSEC source: 0001140361-22-018734 · form4.xml · derivative · entry 4 Georgantas Robert William III · CIK 0001827728 · Chief Scientific Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 29,566 Underlying: Common Stock · 1,971 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · derivative.exercise_price: Each restricted stock unit ("RSU") represents a contingent right to receive one share of Issuer common stock (each, a "Share"). F2 · derivative.exercise_date: These RSUs vest in a series of sixteen successive quarterly installments measured from February 8, 2022, generally subject to the reporting person's continued service with the Issuer, and have no expiration date. F2 · derivative.expiration_date: These RSUs vest in a series of sixteen successive quarterly installments measured from February 8, 2022, generally subject to the reporting person's continued service with the Issuer, and have no expiration date. Read SEC document |
| May 09, 2022 Filed May 12, 2022 01:42 UTC |
Georgantas Robert William IIIChief Scientific Officer
|
Exercise / conversionCommon Stock | 5,647 | Not disclosed | Not disclosed |
DisclosureSEC source: 0001140361-22-018734 · form4.xml · nonDerivative · entry 1 Georgantas Robert William III · CIK 0001827728 · Chief Scientific Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 20,287 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · price: Each restricted stock unit ("RSU") represents a contingent right to receive one share of Issuer common stock (each, a "Share"). F6 · balance_after: Includes 1,262 and 2,604 Shares acquired under the BDSX stock purchase plan on August 31, 2021 and February 28, 2022, respectively. Read SEC document |
| May 09, 2022 Filed May 12, 2022 01:42 UTC |
O'Kane KieranChief Commercial Officer
|
Exercise / conversionRestricted Stock Units · Derivative | 3,972 | $0.00 | $0.00 |
DisclosureSEC source: 0001140361-22-018736 · form4.xml · derivative · entry 4 O'Kane Kieran · CIK 0001828131 · Chief Commercial Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 19,859 Underlying: Common Stock · 3,972 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · derivative.exercise_price: Each restricted stock unit ("RSU") represents a contingent right to receive one share of Issuer common stock (each, a "Share"). F3 · derivative.exercise_date: These RSUs vest in a series of six successive quarterly installments from February 8, 2022, generally subject to the reporting person's continued service with the Issuer, and have no expiration date. F3 · derivative.expiration_date: These RSUs vest in a series of six successive quarterly installments from February 8, 2022, generally subject to the reporting person's continued service with the Issuer, and have no expiration date. Read SEC document |
| May 09, 2022 Filed May 12, 2022 01:42 UTC |
O'Kane KieranChief Commercial Officer
|
Exercise / conversionRestricted Stock Units · Derivative | 1,489 | $0.00 | $0.00 |
DisclosureSEC source: 0001140361-22-018736 · form4.xml · derivative · entry 3 O'Kane Kieran · CIK 0001828131 · Chief Commercial Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 22,342 Underlying: Common Stock · 1,489 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · derivative.exercise_price: Each restricted stock unit ("RSU") represents a contingent right to receive one share of Issuer common stock (each, a "Share"). F2 · derivative.exercise_date: These RSUs vest in a series of sixteen successive quarterly installments measured from February 8, 2022, generally subject to the reporting person's continued service with the Issuer, and have no expiration date. F2 · derivative.expiration_date: These RSUs vest in a series of sixteen successive quarterly installments measured from February 8, 2022, generally subject to the reporting person's continued service with the Issuer, and have no expiration date. Read SEC document |
Value uses the disclosed total when available, otherwise shares × reported transaction price. It is not an estimate of exercise cash cost or investment performance.